Reader View AI Reader View Novartis sees 5% yearly sales growth to 2031, margin back to 40% by 2029 www.investing.com · November 19, 2026 · 06:32 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link